[Salmeterol improves the control of disease in patients with moderate asthma. A comparative study of inhaled salmeterol 50 mg and salbutamol depot tablets 8 mg, both administered twice daily]
- PMID: 8701511
[Salmeterol improves the control of disease in patients with moderate asthma. A comparative study of inhaled salmeterol 50 mg and salbutamol depot tablets 8 mg, both administered twice daily]
Abstract
In a randomized, double-blind, double-dummy, cross-over study the efficacy and safety of inhaled salmeterol 50 mcg (b.i.d.) was compared with oral salbutamol controlled release 8 mg (b.i.d.). Fifty-nine patients with moderate asthma were randomized to two four-week periods of treatment with a two-week washout period. During the study period the patients were allowed to use inhaled Salbutamol on a prn. basis. Inhaled steroids, if any, were continued. On diary cards patients recorded peak expiratory flow rate (PEFR) morning and evening before medication, asthma symptom score, and use of inhaled salbutamol. Salmeterol was more effective than salbutamol CR in decreasing daily symptoms (p = 0.001) and increasing morning-PEFR (p = 0.004). Salmeterol resulted in significantly more days without symptoms (p = 0.0004) and days and nights without need for rescue medication (p = 0.01 and p = 0.01). Salmeterol was better tolerated than salbutamol CR.
Similar articles
-
[Salmeterol improves control in asthmatic patients treated in general practice. A comparative study of salmeterol (Serevent) and salbutamol (Ventoline) in patients with mild to moderate asthma].Ugeskr Laeger. 1995 Jan 2;157(1):36-40. Ugeskr Laeger. 1995. PMID: 7839545 Clinical Trial. Danish.
-
Comparative study of extended release albuterol sulfate and long-acting inhaled salmeterol xinafoate in the treatment of nocturnal asthma.Ann Allergy Asthma Immunol. 1999 Aug;83(2):121-6. doi: 10.1016/S1081-1206(10)62622-1. Ann Allergy Asthma Immunol. 1999. PMID: 10480584 Clinical Trial.
-
[Therapy of nocturnal asthma: salmeterol versus nocturnal administration of retard theophylline--comparison of effectiveness and tolerance].Pneumologie. 1997 Mar;51(3):317-23. Pneumologie. 1997. PMID: 9173422 Clinical Trial. German.
-
Salmeterol. An appraisal of its quality-of-life benefits and potential pharmacoeconomic positioning in asthma.Pharmacoeconomics. 1995 Jun;7(6):562-74. doi: 10.2165/00019053-199507060-00010. Pharmacoeconomics. 1995. PMID: 10155341 Review.
-
Controlled--release salbutamol tablets.Drug Ther Bull. 1990 Jul 23;28(15):58-9. Drug Ther Bull. 1990. PMID: 2131214 Review. No abstract available.
Cited by
-
Step 4: stick or twist? A review of asthma therapy.BMJ Open Respir Res. 2016 Sep 5;3(1):e000143. doi: 10.1136/bmjresp-2016-000143. eCollection 2016. BMJ Open Respir Res. 2016. PMID: 27651907 Free PMC article.
-
Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma.Cochrane Database Syst Rev. 2002;2002(4):CD003901. doi: 10.1002/14651858.CD003901. Cochrane Database Syst Rev. 2002. PMID: 12519616 Free PMC article. Review.
-
Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma.Cochrane Database Syst Rev. 2010 Apr 14;(4):CD005533. doi: 10.1002/14651858.CD005533.pub2. Cochrane Database Syst Rev. 2010. PMID: 20393943 Free PMC article. Review.
-
Regular treatment with salmeterol for chronic asthma: serious adverse events.Cochrane Database Syst Rev. 2008 Jul 16;(3):CD006363. doi: 10.1002/14651858.CD006363.pub2. Cochrane Database Syst Rev. 2008. PMID: 18646149 Free PMC article. Review.
-
Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children.Cochrane Database Syst Rev. 2010 May 12;(5):CD005535. doi: 10.1002/14651858.CD005535.pub2. Cochrane Database Syst Rev. 2010. PMID: 20464739 Free PMC article. Review.